|
|||||
|
|
Re: Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase III Trial (30906) |
|
| Authors: | Mehraban Darab Esfahani Fatemeh |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |